|
1
|
Rodriguez-Barrueco R, Nekritz EA, Bertucci
F, Yu J, Sanchez-Garcia F, Zeleke TZ, Gorbatenko A, Birnbaum D,
Ezhkova E, Cordon-Cardo C, et al: miR-424(322)/503 is a breast
cancer tumor suppressor whose loss promotes resistance to
chemotherapy. Genes Dev. 31:553–566. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheng Y, Dong L, Zhang J, Zhao Y and Li Z:
Recent advances in microRNA detection. Analyst. 2018. View Article : Google Scholar
|
|
4
|
Rapado-González Ó, Majem B, Muinelo-Romay
L, Álvarez-Castro A, Santamaría A, Gil-Moreno A, López-López R and
Suárez-Cunqueiro MM: Human salivary microRNAs in Cancer. J Cancer.
9:638–649. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Horak M, Novak J and Bienertova-Vasku J:
Muscle-specific microRNAs in skeletal muscle development. Dev Biol.
410:1–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Harding RL and Velleman SG: MicroRNA
regulation of myogenic satellite cell proliferation and
differentiation. Mol Cell Biochem. 412:181–195. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakagawa R, Leyland R, Meyer-Hermann M, Lu
D, Turner M, Arbore G, Phan TG, Brink R and Vigorito E:
MicroRNA-155 controls affinity-based selection by protecting c-MYC+
B cells from apoptosis. J Clin Invest. 126:377–388. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saito Y, Nakaoka T and Saito H:
microRNA-34a as a therapeutic agent against human cancer. J Clin
Med. 4:1951–1959. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Singh RP, Massachi I, Manickavel S, Singh
S, Rao NP, Hasan S, Mc Curdy DK, Sharma S, Wong D, Hahn BH and
Rehimi H: The role of miRNA in inflammation and autoimmunity.
Autoimmun Rev. 12:1160–1165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bertoli G, Cava C and Castiglioni I:
MicroRNAs: New biomarkers for diagnosis, prognosis, therapy
prediction and therapeutic tools for breast cancer. Theranostics.
5:1122–1143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hou LK, Yu Y, Xie YG, Wang J, Mao JF,
Zhang B, Wang X and Cao XC: miR-340 and ZEB1 negative feedback loop
regulates TGF-β-mediated breast cancer progression. Oncotarget.
7:26016–26026. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shimono Y, Mukohyama J, Nakamura S and
Minami H: MicroRNA regulation of human breast cancer stem cells. J
Clin Med. 5:2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takahashi RU, Miyazaki H and Ochiya T: The
roles of micrornas in breast cancer. Cancers(Basel). 7:598–616.
2015.PubMed/NCBI
|
|
15
|
Wang B, Teng Y and Liu Q: MicroRNA-153
regulates NRF2 expression and is associated with breast
carcinogenesis. Clin Lab. 62:39–47. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meshkat M, Tanha HM, Naeini MM, Ghaedi K,
Sanati MH, Meshkat M and Bagheri F: Functional SNP in stem of
mir-146a affects Her2 status and breast cancer survival. Cancer
Biomark. 17:213–222. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Majer A, Blanchard AA, Medina S, Booth SA
and Myal Y: Claudin 1 expression levels affect miRNA dynamics in
human basal-like breast cancer cells. DNA Cell Biol. 35:328–339.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schanza LM, Seles M, Stotz M, Fosselteder
J, Hutterer GC, Pichler M and Stiegelbauer V: MicroRNAs associated
with von hippel-lindau pathway in renal cell carcinoma: A
comprehensive review. Int J Mol Sci. 18:2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kagiya T: MicroRNAs: Potential biomarkers
and therapeutic targets for alveolar bone loss in periodontal
disease. Int J Mol Sci. 17:E13172016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jansson MD and Lund AH: MicroRNA and
cancer. Mol Oncol. 6:590–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ohtsuka M, Ling H, Doki Y, Mori M and
Calin GA: MicroRNA processing and human cancer. J Clin Med.
4:1651–1667. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Blenkiron C, Goldstein LD, Thorne NP,
Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE,
Green AR, Ellis IO, et al: MicroRNA expression profiling of human
breast cancer identifies new markers of tumor subtype. Genome Biol.
8:R2142007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schayek H, Korach H, Laitman Y,
Bernstein-Molho R and Friedman E: Mutational analysis of candidate
genes in Israeli male breast cancer cases. Breast Cancer Res Treat.
2018. View Article : Google Scholar
|
|
27
|
Drost R and Jonkers J: Opportunities and
hurdles in the treatment of BRCA1-related breast cancer. Oncogene.
33:3753–3763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Narod SA and Foulkes WD: BRCA1 and BRCA2:
1994 and beyond. Nat Rev Cancer. 4:665–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
